microR-505/heterogeneous nuclear ribonucleoprotein M inhibits hepatocellular carcinoma cell proliferation and induces cell apoptosis through the Wnt/ β-catenin signaling pathway.
Conclusion: The results suggest that the regulation of miR-505/HNRNPM may be a novel strategy to improve the targeted therapy of HCC.
PMID: 32940078 [PubMed - in process]
Source: Future Medicine: Biomarkers in Medicine - Category: Internal Medicine Tags: Biomark Med Source Type: research
More News: Cancer & Oncology | Carcinoma | Genetics | Hepatocellular Carcinoma | Internal Medicine | Liver Cancer | Study